The Pharmaceutical Development & Analytical unit of Scantox covers strong Bioanalysis capabilities, as well as Pharmaceutical Development services.
We develop formulations, from concept idea to clinical proof of concept, and the formulation technology platform provides innovative products having unique benefits regarding efficacy, safety and convenience thereby meeting the needs from patients, doctors and society alike for the treatment of important medical conditions.
Our Bioanalytical team has a deep understanding of LC-MS/MS bioanalysis of small molecules and a long regulatory track record. Scantox stands out in this field for our ability to deliver tailored problem-solving experience for complex bioanalytical challenges of new molecules.
Why Scantox
- Extensive experience with different types of analytes and LCMS/MS bioanalytical method development and validation
- Engagement & Reliability: Committed to flexibility and maintaining open lines of communication, both within our team and with sponsors, to ensure project needs are understood and met. Reputation on meeting actual timelines.
- Tailored Solutions: The focus lies on developing lean, cost-effective, and reliable methods designed to address unique client needs.
- Extensive experience with pre-formulation to ensure drugability, formulations development as well as GMP manufacture of investigational medicinal products incl. primary and secondary packaging for phase 1 and 2 clinical trials.
- Extensive experience with analytical method development, validation and QC release as well as ICH stability testing.
